Estimated impacts of mandatory sodium reformulation targets on sodium consumption, health outcomes, health sector costs and health equity in Aotearoa New Zealand
- 1University of Auckland
Abstract
Aims Cardiovascular disease (CVD) is the leading cause of death in Aotearoa New Zealand (NZ), including for M[a]ori, the Indigenous population. Sodium intake is a modifiable CVD risk factor. In 2021, the World Health Organization (WHO) released sodium reduction benchmarks for 58 packaged food categories. We aimed to estimate the health, health-sector cost, and equity impacts of mandating these benchmarks in NZ. Methods Nationally representative data on household food purchases, packaged food sodium content, and dietary intake were used to estimate baseline sodium consumption (2011) and changes following implementation of the WHO benchmarks. A dietary multi-state life-table model estimated impacts on health-adjusted life years (HALYs) and health system costs (2011 NZ$, 3% discount rate) over the remaining lifetime of the 2011 NZ population (n = 4.4 million). Analyses examined impacts by sex and for M[a]ori. Results Mandatory reformulation was estimated to reduce sodium intake by 470 mg/day per person (1.18 g salt), a 22% reduction from baseline. Across population groups, age-standardised reductions ranged from 380 to 660 mg/day (22-23%), generating an estimated 55,600 HALYs (95% uncertainty interval 19,100-90,000) and NZ$535.2 million in health-system cost savings (95% UI: 183.0-914.6 million) over the population lifetime. M[a]ori gained 11,600 HALYs (95% UI: 4,900-17,700), equivalent to 17.2 HALYs per 1,000 population, compared with 11.8 per 1,000 among non-M[a]ori. Conclusion Mandating WHO sodium benchmarks in NZ could substantially reduce sodium intake, improve population health, reduce health sector costs, and advance health equity. Findings support adoption of this strategy in Aotearoa NZ.
Related
- Health risks of alcohol consumption in Aotearoa New Zealand: modelling to inform low-risk-drinking guidelines.
- Ventilator brand, not ventilation mode, determines electricity consumption and estimated carbon emissions: a bench study of nine intensive care ventilators
- Intensive care admissions, experiences and outcomes for Indigenous children in Australia, Aotearoa (New Zealand), Canada and the USA: a scoping review protocol
- Effects of a 12-Week Zumba Training Program on Estimated Aerobic Capacity and Exploratory Hematological and Inflammatory Outcomes in Overweight/Obese Postmenopausal Women: A Pilot Randomized Controlled Trial.
- Alcohol Consumption and Associations With Short‐ and Long‐Term Outcomes in Low Back Pain: A Longitudinal Case‐Crossover Study
BibTeX
@misc{fuavao2026estimated,
title = {{Estimated impacts of mandatory sodium reformulation targets on sodium consumption, health outcomes, health sector costs and health equity in Aotearoa New Zealand}},
author = {K. Fuavao and C. Cleghorn and B. McKenzie and N. Widyastuti and R. McLean and B. Swinburn and C. Ni Mhurchu and V. Nosa and H. Eyles},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.03.26367203},
url = {https://www.medrxiv.org/content/10.64898/2026.11.03.26367203v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Estimated impacts of mandatory sodium reformulation targets on sodium consumption, health outcomes, health sector costs and health equity in Aotearoa New Zealand
AU - K. Fuavao
AU - C. Cleghorn
AU - B. McKenzie
AU - N. Widyastuti
AU - R. McLean
AU - B. Swinburn
AU - C. Ni Mhurchu
AU - V. Nosa
AU - H. Eyles
PY - 2026
DA - 2026/11/03
PB - medRxiv
DO - 10.64898/2026.11.03.26367203
UR - https://www.medrxiv.org/content/10.64898/2026.11.03.26367203v1
AB - Aims Cardiovascular disease (CVD) is the leading cause of death in Aotearoa New Zealand (NZ), including for M[a]ori, the Indigenous population. Sodium intake is a modifiable CVD risk factor. In 2021, the World Health Organization (WHO) released sodium reduction benchmarks for 58 packaged food categories. We aimed to estimate the health, health-sector cost, and equity impacts of mandating these benchmarks in NZ. Methods Nationally representative data on household food purchases, packaged food sodium content, and dietary intake were used to estimate baseline sodium consumption (2011) and changes following implementation of the WHO benchmarks. A dietary multi-state life-table model estimated impacts on health-adjusted life years (HALYs) and health system costs (2011 NZ$, 3% discount rate) over the remaining lifetime of the 2011 NZ population (n = 4.4 million). Analyses examined impacts by sex and for M[a]ori. Results Mandatory reformulation was estimated to reduce sodium intake by 470 mg/day per person (1.18 g salt), a 22% reduction from baseline. Across population groups, age-standardised reductions ranged from 380 to 660 mg/day (22-23%), generating an estimated 55,600 HALYs (95% uncertainty interval 19,100-90,000) and NZ$535.2 million in health-system cost savings (95% UI: 183.0-914.6 million) over the population lifetime. M[a]ori gained 11,600 HALYs (95% UI: 4,900-17,700), equivalent to 17.2 HALYs per 1,000 population, compared with 11.8 per 1,000 among non-M[a]ori. Conclusion Mandating WHO sodium benchmarks in NZ could substantially reduce sodium intake, improve population health, reduce health sector costs, and advance health equity. Findings support adoption of this strategy in Aotearoa NZ.
ER -